Conv. Plasma
Nigella Sativa
Peg.. Lambda

All vitamin D studies
Meta analysis
Home COVID-19 treatment researchVitamin DVitamin D (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Mortality 29% Improvement Relative Risk Vitamin D for COVID-19  Baktash et al.  Sufficiency Are vitamin D levels associated with COVID-19 outcomes? Prospective study of 70 patients in the United Kingdom Lower mortality with higher vitamin D levels (not stat. sig., p=0.5) Baktash et al., Postgraduate Medical J., Aug 2020 Favors vitamin D Favors control

Vitamin D status and outcomes for hospitalised older patients with COVID-19

Baktash et al., Postgraduate Medical Journal, doi:10.1136/postgradmedj-2020-138712
Aug 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
Prospective study of 105 hospitalized patients, showing lower vitamin D levels in the COVID-19 positive group (27.0 nmol/L vs 52.0 nmol/L, p=0.0008), and non-statistically significant higher mortality with vitamin D deficiency.
This is the 11th of 184 COVID-19 sufficiency studies for vitamin D, which collectively show higher levels reduce risk with p<0.0000000001 (1 in 712 vigintillion).
risk of death, 28.6% lower, RR 0.71, p = 0.50, high D levels 4 of 31 (12.9%), low D levels 6 of 39 (15.4%), adjusted per study, inverted to make RR<1 favor high D levels, >30nmol/L.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Baktash et al., 27 Aug 2020, prospective, United Kingdom, peer-reviewed, 8 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperVitamin DAll
Vitamin D status and outcomes for hospitalised older patients with COVID-19
Vadir Baktash, Tom Hosack, Nishil Patel, Shital Shah, Pirabakaran Kandiah, Koenraad Van Den Abbeele, Amit K J Mandal, Constantinos G Missouris
Postgraduate Medical Journal, doi:10.1136/postgradmedj-2020-138712
Purpose Older adults are more likely to be vitamin D deficient. The aim of the study was to determine whether these patients have worse outcomes with COVID-19. Methods We conducted a prospective cohort study between 1 March and 30 April 2020 to assess the importance of vitamin D deficiency in older patients with COVID-19. The cohort consisted of patients aged ≥65 years presenting with symptoms consistent with COVID-19 (n=105). All patients were tested for serum 25hydroxyvitamin D (25(OH)D) levels during acute illness. Diagnosis of COVID-19 was confirmed via viral reverse transcriptase PCR swab or supporting radiological evidence. COVID-19-positive arm (n=70) was sub-divided into vitamin D-deficient (≤30 nmol/L) (n=39) and -replete groups (n=35). Subgroups were assessed for disease severity using biochemical, radiological and clinical markers. Primary outcome was in-hospital mortality. Secondary outcomes were laboratory features of cytokine storm, thoracic imaging changes and requirement of non-invasive ventilation (NIV). Results COVID-19-positive arm demonstrated lower median serum 25(OH)D level of 27 nmol/L (IQR=20-47 nmol/L) compared with COVID-19-negative arm, with median level of 52 nmol/L (IQR=31.5-71.5 nmol/L) (p value=0.0008). Among patients with vitamin D deficiency, there was higher peak D-dimer level (1914.00 μgFEU/L vs 1268.00 μgFEU/L) (p=0.034) and higher incidence of NIV support and high dependency unit admission (30.77% vs 9.68%) (p=0.042). No increased mortality was observed between groups. Conclusion Older adults with vitamin D deficiency and COVID-19 may demonstrate worse morbidity outcomes. Vitamin D status may be a useful prognosticator.
Contributors All authors contributed to the manuscript. All were involved in the design of the study. VB, PK and NP collected the data. VB and TH were responsible for the statistical analysis. VB, TH, AKJM, KVDA, SS and CGM wrote the manuscript and all authors were involved in the final approval of the manuscript. Competing interests All authors understand the policy of declaration of interests. CGM is a former member of the Fellowship of Postgraduate Medicine (FPM) council and is currently an FPM Fellow. VB, TH, NP, SS, PK, KVDA, AKJM all declare that they have no competing interests. Patient consent for publication Not required. Ethics approval As an audit using clinically collected, non-identifiable data, this work does not fall under the remit of National Health Service Research Ethics Committees. This statement is also present in the 'Methods and material' section of our manuscript. Provenance and peer review Not commissioned; externally peer reviewed. Main messages • Older patients with COVID-19 infection and vitamin D deficiency (≤30 nmol/L) have higher peak D-dimer level and higher incidence of NIV support and HDU admission. • Vitamin D deficiency may be associated with worse outcomes from COVID-19, and vitamin D status may be a useful prognosticator. What is already known on the subject • There appears to be an association between increased COVID-19 incidence and mortality and countries with an increased prevalence of vitamin D deficiency. • Vitamin D plays an..
Alipio, Vitamin D Supplementation Could Possibly Improve Clinical Outcomes of Patients Infected with Coronavirus, SSRN Journal, doi:10.2139/ssrn.3571484
Almerighi, Sinistro, Cavazza, 1Alpha,25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes, Cytokine, doi:10.1016/j.cyto.2008.12.009
Barrat, Cua, Boonstra, In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines, J Exp Med, doi:10.1084/jem.20011629
Boonstra, Barrat, Crain, 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells, J Immunol, doi:10.4049/jimmunol.167.9.4974
Cantorna, Mechanisms underlying the effect of vitamin D on the immune system, Proc Nutr Soc, doi:10.1017/S0029665110001722
Charlson, Pompei, Ales, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, doi:10.1016/0021-9681(87)90171-8
D'avolio, Avataneo, Manca, 25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2, Nutrients, doi:10.3390/nu12051359
Dancer, Parekh, Lax, Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS), Thorax, doi:10.1136/thoraxjnl-2014-206680
Daniel, Sartory, Zahn, Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile, J Pharmacol Exp Ther, doi:10.1124/jpet.107.127209
Francis, Aspray, Bowring, National osteoporosis society practical clinical guideline on vitamin D and bone health, Maturitas, doi:10.1016/j.maturitas.2014.11.018
Gibson, Davis, Zhu, Dietary vitamin D and its metabolites non-genomically stabilize the endothelium, PLoS One, doi:10.1371/journal.pone.0140370
Giustina, Adler, Binkley, Controversies in vitamin D: summary statement from an international conference, J Clin Endocrinol Metab, doi:10.1210/jc.2018-01414
Gorman, Kuritzky, Judge, Topically applied 1,25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes, J Immunol, doi:10.4049/jimmunol.179.9.6273
Hastie, Mackay, Ho, Vitamin D concentrations and COVID-19 infection in UK Biobank, Diabetes Metab Syndr, doi:10.1016/j.dsx.2020.04.050
Ilie, Stefanescu, Smith, The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality, Aging Clin Exp Res, doi:10.1007/s40520-020-01570-8
Jose, Manuel, COVID-19 cytokine storm: the interplay between inflammation and coagulation, The Lancet Respiratory Medicine, doi:10.1016/S2213-2600(20)30216-2
Kuka, Imai, Penninger, Angiotensin-converting enzyme 2 in lung diseases, Curr Opin Pharmacol, doi:10.1016/j.coph.2006.03.001
Levi, Thachil, Iba, Levy, Coagulation abnormalities and thrombosis in patients with COVID-19, Lancet Haematol, doi:10.1016/S2352-3026(20)30145-9
Lippi, Plebani, Laboratory abnormalities in patients with COVID-2019 infection, Clin Chem Lab Med, doi:10.1515/cclm-2020-0198
Martineau, Jolliffe, Hooper, Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individuals participant data, BMJ, doi:10.1136/bmj.i6583
Mattner, Smiroldo, Galbiati, Inhibition of Th1 development and treatment of chronic-relapsing experimental allergic encephalomyelitis by a non-hypercalcemic analogue of 1,25-dihydroxyvitamin D(3), Eur J Immunol, doi:10.1002/1521-4141(200002)30:2%3C498::AID-IMMU498%3E3.0.CO;2-Q
Panarese, Shahini, COVID-19, and vitamin D, Aliment Pharm Ther, doi:10.1111/apt.15752
Penna, Roncari, Amuchastegui, Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3, Blood, doi:10.1182/blood-2005-05-2044
Rockwood, Song, Macknight, Global clinical measure of fitness and frailty in elderly people, CMAJ, doi:10.1503/cmaj.050051
Shi, Han, Jiang, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis, doi:10.1016/S1473-3099(20)30086-4
Shorr, Thomas, Alkins, D-dimer correlates with proinflammatory cytokine levels and outcomes in critically ill patients, Chest, doi:10.1378/chest.121.4.1262
Tang, Zhou, Luger, Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response, J Immunol, doi:10.4049/jimmunol.0801543
Wong, Lam, Fong, Frequency and distribution of chest radiographic findings in COVID-19 positive patients, Radiology, doi:10.1148/radiol.2020201160
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop